COPD: Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients

Sponsor
University of Aarhus (Other)
Overall Status
Completed
CT.gov ID
NCT03020862
Collaborator
(none)
15
1
2
20
0.8

Study Details

Study Description

Brief Summary

The purpose is to evaluate exercise performance in patients with Chronic Obstructive Pulmonary Disease (COPD) after supplementing with higher doses of dietary NO3-, compared to previous studies, as beetroot juice for seven days. The secondary purpose is to evaluate oxygen consumption of submaximal cycling, amendments in blood pressure, and physical activity level.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Dietary beetroot juice
N/A

Detailed Description

The purpose is to evaluate exercise performance in patients with Chronic Obstructive Pulmonary Disease (COPD) using the 6-minute walk test (6MWT) after supplementing with higher doses of dietary NO3- compared to previous studies, as beetroot juice for seven days. The secondary purpose is to evaluate oxygen consumption of submaximal cycling, amendments in blood pressure, and physical activity level.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients
Study Start Date :
Dec 1, 2013
Actual Primary Completion Date :
Apr 1, 2014
Actual Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Placebo ---> Dietary beetroot

Placebo was administrated in the first period of the cross-over trial, while the intervention beverage Dietary Beetroot juice was administrated in the second period of the trial. The placebo: was an NO3- negligble drink from James White Drinks England (Beet-it), which was otherwise similar to the dietary beetroot juice in nutrient composition, smell and appearance. Dose: 2x70 mL consumed twice a day for six days. Intervention beverage, Dietary beetroot juice:Consumed as beetroot juice from James White Drinks England (Beet-it) and contained 300 mg dietary nitrate. Dose: 2x70 mL consumed twice a day for six days.

Dietary Supplement: Dietary beetroot juice
Consumed as concentrated beetroot juice from James White Drinks England (Beet-it) and contained 300 mg dietary nitrate. Dose: 2x70 mL consumed twice a day for six days.

Experimental: Dietary beetroot juice --> Placebo

The intervention beverage Dietary beetroot juice was administrated in the first period of the cross-over trial, while placebo was administrated in the second period of the trail Intervention beverage, Dietary beetroot juice:Consumed as beetroot juice from James White Drinks England (Beet-it) and contained 300 mg dietary nitrate. Dose: 2x70 mL consumed twice a day for six days. The placebo: was an NO3- negligble drink from James White Drinks England (Beet-it), which was otherwise similar to the dietary beetroot juice in nutrient composition, smell and appearance. Dose: 2x70 mL consumed twice a day for six days.

Dietary Supplement: Dietary beetroot juice
Consumed as concentrated beetroot juice from James White Drinks England (Beet-it) and contained 300 mg dietary nitrate. Dose: 2x70 mL consumed twice a day for six days.

Outcome Measures

Primary Outcome Measures

  1. Physical performance on 6-min walk test (6MWT) [6 minutes]

Secondary Outcome Measures

  1. Blood Pressure [At baseline and 150 minutes after consumption of beverages]

  2. Plasma Nitrite concentration [Baseline, 150 and 210 minutes after consumption of beverages]

  3. Oxygen consumption during submaximal cycling [Two trials of 6 minutes duration (10 min break between trials)]

  4. Physical activity level [Six days]

    Measured all intervention days except on the day of testing

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Moderate-severe Chronics Obstructive Pulmonary Disease (COPD) (FEV1 <80% of predicted).
Exclusion Criteria:
  • Smoking,

  • failure to complete physical testing,

  • on-going participation in rehabilitation programs,

  • pacemaker or use of nicotine products,

  • oxygen mask,

  • beta blockers,

  • antibacterial mouthwash,

  • chewing gum or stomach-neutralizing medicine during the intervention.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sport Science, Department of Public Health, Aarhus University Aarhus Denmark 8000

Sponsors and Collaborators

  • University of Aarhus

Investigators

  • Principal Investigator: Mette Hansen, Aarhus University, Department for Public Health, Section for Sport Sciene

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT03020862
Other Study ID Numbers:
  • D2013A2014
First Posted:
Jan 13, 2017
Last Update Posted:
Jan 16, 2017
Last Verified:
Jun 1, 2014
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by University of Aarhus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 16, 2017